Interpace Diagnostics Group Inc is engaged in developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for diagnosis and management.
| Website: | www.interpacediagnostics.com |
| Email: | mcarey@rxir.com |
| Main Phone: | +1 844 405-9655 |
| Address: | 300 Interpace Parkway |
| Address 2: | Building A |
| State: | NJ |
| City / Town: | Parsippany |
| Country: | USA |
| Postal Code: | 07054 |
| Exchange: | NSC |
| Employees: | 65 |
| NAICS: | Testing Laborato |
| Last Price 0.99 | Change $ 0.01 | Change % 1.02 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 1.05 | Ask Size 3,800.00 |
| Open 1.06 | High 1.07 | Low 0.98 | Prev Close 0.98 |
| Last Trade | Volume 5.3 mi | 52 Wk Hi 19.80 | 52 Wk Low 0.70 |
| Market Cap 18.5 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 18,688,604.00 | EPS (TTM) -1.34 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 8 |
| Number of Buys | 0 | 4 |
| Number of Sells | 0 | 4 |
| Net Activity | 0 | 379597 |
| Last 10 Buys | Shares |
|---|---|
| Graham G. Miao | 1,000 |
| Graham G. Miao | 1,000 |
| Nancy Lurker | 1,000 |
| Gerald R. Melillo | 1,000 |
| Nancy Lurker | 1,000 |
| Jeffrey E. Smith | 1,000 |
| Jeffrey E. Smith | 1,000 |
| Nancy Lurker | 1,000 |
| Nancy Lurker | 1,000 |
| Nancy Lurker | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Gerald R. Melillo | 1,000 |
| Gerald R. Melillo | 1,000 |
| Gerald R. Melillo | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 3 | 3 | 3 | 3 |
| Low Target Price Estimate | 3 | 3 | 3 | 3 |
| Mean Target Price Estimate | 3 | 3 | 3 | 3 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 08/24/15 | 08/24/15 | 08/24/15 | 08/24/15 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 12 | 2016-08-16 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 35 | 2016-08-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 16 | 2016-08-08 |
| DEFA14A | Additional proxy soliciting materials - definitive | 3 | 2016-07-25 |
| DEFA14A | Additional proxy soliciting materials - definitive | 4 | 2016-07-21 |
| DEFA14A | Additional proxy soliciting materials - definitive | 5 | 2016-07-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-07-11 |
| DEFA14A | Additional proxy soliciting materials - definitive | 3 | 2016-06-22 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 65 | 2016-06-22 |
| 8-K/A | Amendment to a previously filed 8-K | 22 | 2016-06-22 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
